Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
3.4K Views
•
12:04 min
•
March 10th, 2023
DOI :
March 10th, 2023
•1Division of Hematology, Department of Internal Medicine, Medical University of Graz, 2Division of Hematology, Stanford Cancer Institute, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 3Department of Blood Group Serology and Transfusion Medicine, Medical University of Graz
Chapters in this video
0:05
Introduction
0:54
sgRNA Design
1:57
Homology-Directed Repair Vector Construction
5:42
Editing of Hematopoietic Stem and Progenitor Cells
9:48
Results: Heterozygous Gain-of-Function Mutations in Hematopoietic Stem and Progenitor Cells by Combining the Use of CRISPR/Cas9 and Dual rAAV Donor Transduction
11:19
Conclusion
Related Videos
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
24.2K Views
11:30
Colony Forming Cell (CFC) Assay for Human Hematopoietic Cells
35.5K Views
08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
15.1K Views
05:45
In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
7.8K Views
11:06
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
12.9K Views
10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
9.8K Views
10:25
Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
9.2K Views
08:14
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
12.0K Views
06:28
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
1.6K Views
08:32
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
3.4K Views
Copyright © 2025 MyJoVE Corporation. All rights reserved